Skip to main content
. Author manuscript; available in PMC: 2015 Jan 1.
Published in final edited form as: J Diabetes Complications. 2013 Mar 7;28(1):101–109. doi: 10.1016/j.jdiacomp.2013.01.006

Table 3. Comparison of successful long-term glycemic control between participants in the IS versus the IP arm.

Simple percentages and odds ratios (OR) of IS/IP success rates from logistic regression models

Successful Long-Term Glycemic Control (Success) During Follow-up

All participants

IP Arm IS Arm OR: IS / IP 95% C.I.


N % Success N % Success

962 24.4 955 35.1 1.67 1.37, 2.04

Insulin therapy at baseline
 No Insulin (N=1393) 689 25.7 704 43.8 2.25 1.79, 2.82

 Insulin (N=524) 273 21.2 251 10.8 0.45 0.27, 0.73

Test for heterogeneity1 of ORs p<0.0001

HbA1c at baseline
 <6.0% 105 37.1 97 60.8 2.63 1.49, 4.64

 6.0-6.5% 139 30.9 156 50.6 2.29 1.42, 3.69

 6.6-7.0% 147 32.0 134 45.5 1.78 1.09, 2.89

 >7.0% 571 18.6 568 23.9 1.38 1.04, 1.84

Test for heterogeneity1 of ORs p=0.12

Age at baseline
 <50 yrs 81 11.1 86 31.4 3.66 1.60, 8.38

 50-60 yrs 349 18.6 349 32.7 2.12 1.49, 3.01

 61-70 yrs 381 26.0 342 36.3 1.62 1.18, 2.23

 >70 yrs 151 41.1 178 39.3 0.93 0.60, 1.45

Test for heterogeneity1 of ORs p=0.008

Duration of DM
 < 5 yrs 370 23.2 389 49.1 3.19 2.33, 4.36

 5-10 yrs 198 23.7 221 33.9 1.65 1.07, 2.54

 11-20 yrs 273 25.3 259 22.4 0.85 0.57, 1.27

 > 20 yrs 121 27.3 86 12.8 0.39 0.19, 0.83

Test for heterogeneity1 of ORs p<0.0001

Level of physical activity
 Sedentary or mild 591 26.9 605 33.2 1.35 1.06, 1.73

 Moderate or strenuous 371 20.5 350 38.3 2.41 1.73, 3.36

Test for heterogeneity1 of ORs p=0.006

Basal insulin
 ≤ 5 μIU/ml** 166 24.1 188 31.9 1.48 0.92, 2.36

 > 5 μIU/ml** 737 24.4 710 35.5 1.70 1.36, 2.14

Test for heterogeneity1 of ORs p=0.59
1

Interaction between randomization arm (IS or IP) and each row variable.

**

multiply by 6.945 to obtain pmol/L